On January 7, 2020, a novel coronavirus (SARS-CoV-2) was identified as the causative agent of a cluster of pneumonia of unknown origin detected in Wuhan City by Chinese authorities. Since SARS-CoV-2 discovery, the corresponding disease (COVID-19) has rapidly expanded throughout the globe, making as a consequence the World Health Organization (WHO) declaring a pandemic. As of May 19, 2020, over 4.806.299 cases of COVID-19 had been confirmed worldwide, with more than 318.599 deaths.
Defining the clinical phenotype of COVID-19 in children / V. Giacomet, M. Stracuzzi, L. Paradiso, M.E. Di Cosimo, V. Rubinacci, G. Zuccotti. - In: PEDIATRIC ALLERGY AND IMMUNOLOGY. - ISSN 1399-3038. - 31:Suppl. 26(2020), pp. 82-84. [10.1111/pai.13355]
Defining the clinical phenotype of COVID-19 in children
V. Giacomet
Primo
;G. Zuccotti
2020
Abstract
On January 7, 2020, a novel coronavirus (SARS-CoV-2) was identified as the causative agent of a cluster of pneumonia of unknown origin detected in Wuhan City by Chinese authorities. Since SARS-CoV-2 discovery, the corresponding disease (COVID-19) has rapidly expanded throughout the globe, making as a consequence the World Health Organization (WHO) declaring a pandemic. As of May 19, 2020, over 4.806.299 cases of COVID-19 had been confirmed worldwide, with more than 318.599 deaths.
| File | Dimensione | Formato | |
|---|---|---|---|
|
pai.13355.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
230.49 kB
Formato
Adobe PDF
|
230.49 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
